G Bouvenot
Impact in
-
- Antibiotic Use and Resistance
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 20
- Pharmaceutical Economics and Policy 14
-
- Pharmaceutical Practices and Patient Outcomes 8
- Co-authors
- Claude Carbón (3 shared papers)Beverley Balkau (3 shared papers)Françoise Vauzelle-Kervroedan (3 shared papers)Didier Guillemot (3 shared papers)Eveline Eschwège (2 shared papers)Pierre Geslin (1 shared paper)P. Villani (13 shared papers)É. Eschwège (4 shared papers)
In The Last Decade
G Bouvenot
85 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 131
- Applied Microbiology and Biotechnology 236
- Rheumatology 336
- Molecular Medicine 105
- Orthopedics and Sports Medicine 141
- Pharmacology 231
Countries citing papers authored by G Bouvenot
This map shows the geographic impact of G Bouvenot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bouvenot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bouvenot more than expected).
Fields of papers citing papers by G Bouvenot
This network shows the impact of papers produced by G Bouvenot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bouvenot. The network helps show where G Bouvenot may publish in the future.
Co-authors
The 25 scholars most cited alongside G Bouvenot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 467 | |
| 2 | 1996 | 112 | |
| 3 | 2004 | 111 | |
| 4 | 2007 | 98 | |
| 5 | 1998 | 66 | |
| 6 | 2004 | 64 | |
| 7 | 1998 | 63 | |
| 8 | 1998 | 48 | |
| 9 | 2004 | 39 | |
| 10 | 1995 | 34 | |
| 11 | 1999 | 29 | |
| 12 | Effect of age on different receptors and functions of phagocytic cells. | 1984 | 24 |
| 13 | 1998 | 22 | |
| 14 | [Targeted anti-cytokine therapies for osteoarthritis]. | 2006 | 20 |
| 15 | 2005 | 19 | |
| 16 | 1988 | 18 | |
| 17 | 2006 | 17 | |
| 18 | [Chronopharmacokinetics of digoxin in patients over 70 years of age]. | 1988 | 15 |
| 19 | Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology. | 1989 | 15 |
| 20 | 1996 | 15 |
About G Bouvenot
G Bouvenot is a scholar working on Economics and Econometrics, Geriatrics and Gerontology, Pharmacology, General Health Professions and Rheumatology, having authored 95 papers that have together received 1.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical Economics and Policy (14 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Healthcare Systems and Practices (7 papers), Health, Medicine and Society (7 papers), Pharmaceutical studies and practices (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Pharmaceutical industry and healthcare (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (236 citations), Rheumatology (336 citations), Molecular Medicine (105 citations), Orthopedics and Sports Medicine (141 citations) and Pharmacology (231 citations). G Bouvenot has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Claude Carbón, Beverley Balkau, Françoise Vauzelle-Kervroedan, Didier Guillemot, Eveline Eschwège, Pierre Geslin, P. Villani, É. Eschwège, Bernard P. Avouac and Pı̈erre Ambrosi. Their work appears in journals such as Calcified Tissue International, Chronobiology International, Osteoporosis International, Health Policy and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.